Current position:Home >Product >
N-[[4-(3-fluorophenyl)sulfonyl-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]methyl]-N-phenyl-cyclopropanecarboxamide
N-[[4-(3-fluorophenyl)sulfonyl-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]methyl]-N-phenyl-cyclopropanecarboxamide
|
|
Canonical SMILES:
C1CC1C(=O)N(CC2=CC3=C(C=C2)OCCN(C3)S(=O)(=O)C4=CC=CC(=C4)F)C5=CC=CC=C5
Isomeric SMILES
C1CC1C(=O)N(CC2=CC3=C(C=C2)OCCN(C3)S(=O)(=O)C4=CC=CC(=C4)F)C5=CC=CC=C5
InChI
InChI=1S/C26H25FN2O4S/c27-22-5-4-8-24(16-22)34(31,32)28-13-14-33-25-12-9-19(15-21(25)18-28)17-29(26(30)20-10-11-20)23-6-2-1-3-7-23/h1-9,12,15-16,20H,10-11,13-14,17-18H2
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- N-[[4-(2-fluorophenyl)sulfonyl-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]methyl]-N-phenyl-cyclopropanecarboxamide
- N-[[4-[2,5-bis(fluoranyl)phenyl]sulfonyl-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]methyl]-N-phenyl-cyclopropanecarboxamide
- [1-methyl-3-[(4-methylphenyl)methoxymethyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-(3,4,5-trimethoxyphenyl)methanone
- N-[[4-[3,4-bis(fluoranyl)phenyl]sulfonyl-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]methyl]-N-phenyl-cyclopropanecarboxamide
- 2-(4-fluoranylphenoxy)-1-[1-methyl-3-[(4-methylphenyl)methoxymethyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone
- N-[[4-[3,5-bis(fluoranyl)phenyl]sulfonyl-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]methyl]-N-phenyl-cyclopropanecarboxamide
- 1-methyl-5-(4-methylphenyl)sulfonyl-3-(phenylmethoxymethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine
- N-methyl-N-(phenylmethyl)-4-(3-phenyl-1,2,4-oxadiazol-5-yl)quinolin-2-amine
- 5-(5-bromanylthiophen-2-yl)sulfonyl-1-methyl-3-(phenylmethoxymethyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine
- 5-[2-(3,4-dihydro-1H-isoquinolin-2-yl)quinolin-4-yl]-3-phenyl-1,2,4-oxadiazole

